University of Maryland School of Medicine logo
Maryland Addiction Consultation Service (MACS)
All Departments
UMSOM Assistant

Medications for Opioid Use Disorder (MOUD)

  • Home
  • MACS
  • Resources
  • Medications for Opioid Use Disorder (MOUD)
  • Resources
  • Overview
  • MOUD Overview
  • Stigma in Healthcare Settings
  • MACS Materials & Fact Sheets
  • Practice Guidance & Clinical Resources
  • MACS Monthly Newsletter
  • MAT & MATE Acts

Medications for Opioid Use Disorders (MOUD) involve a combination of medications that targets the brain, and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone. More from PCSS.

Buprenorphine is one of three medications approved by the FDA for the treatment of opioid use disorder. MACS’ team of expert addiction medicine specialists provide trainings for Maryland prescribers on best practices for providing buprenorphine and caring for individuals with OUD. We also provide technical assistance support for prescribers and their practices to grow office-based services for opioid use disorders.

The removal of the waiver previously required to prescribe buprenorphine, makes providing life-saving treatment for opioid use disorder easier.

Additional Training Resources

  • PCSS-MOUD
  • ASAM
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map